Breitbart News Daily Podcast Ep. 15: CBO Exposes Build Back Better Hoax, Commie from Cornell Bombs in Senate, Guest Vivek Ramaswamy on Woke Industrial Complex

On today’s Breitbart News Daily Podcast, host Alex Marlow covers House Republican Minority Leader Kevin McCarthy’s record-breaking 8 hour and 32 minute speech on the House floor opposing Biden’s Build Back Better bill, which costs way more than President Brandon promised it would, according to the mostly Democrat Congressional Budget Office. Then, President Biden’s pick for Comptroller of the Currency, Saule Omarova (a.k.a. the Commie from Cornell), somehow fared even worse than we expected in her Senate grilling. Also, did a Substack citizen journalist crack the code on Ivermectin? Maybe the “dewormer” narrative wasn’t entirely a hoax after-all! Today’s guest interview is a special long-form discussion with prodigy biopharmaceuticals CEO-turned culture warrior Vivek Ramaswamy. The Woke, Inc. author details how the government is using corporations to backdoor a radical agenda, which he considers an existential threat to our republic.

The Breitbart News Daily Podcast runs Monday through Friday as a “Director’s Cut” of the SXM Patriot radio show. Hosted by Breitbart Editor-in-Chief Alex Marlow, you’ll hear Alex’s take on the big political stories, interviews with various newsmakers, and the Patriot “Caller of the Day.”

SUBSCRIBE for free by clicking your preferred podcast platform below.

Source

Hippo Sighting Report

Help us out, we really appreciate it.

Help contribute to our research, and let us know if you have seen similar situations that we may have missed. Our team will review the details you provide and add to our main list once we verify the information.

stay informed

Subscribe and get the updated Hippo List.

Get notified when we release our updated lists by email.

Make a Donation

Thank you for subscribing!

We will send you an email to confirm your details.  Welcome aboard!

Thanks for sending us your report.

We will review your information, and publish in on our list once we validate the details.